Regulated cell death in cerebral infarction: a switch-aware framework from molecular mechanisms to targeted therapy
BackgroundCerebral infarction remains a leading cause of death and long-term disability. Although reperfusion therapy has transformed early management, its benefit is limited by narrow time windows, and most neuroprotective monotherapies have failed in translation.